Any current/future new fundraising through debt or equity?

No immediate plans for new fundraising through debt or equity as the company's cash accruals and expansion plans are well synchronized. Shareholder approval for issuance of share debentures exists as an enabling provision to avoid last-minute rush if capital is needed, but currently, there is no requirement for additional capital. Future expansions beyond March 2026 will be funded primarily through internal cash profits, following past practices. The company will evaluate further plans after successful implementation of the current plant and year-end financial results. Listing on BSE i

Any current/future capex/capital investment/strategic investment?

Current capex: Ongoing 50% expansion of NPK/DAP capacity at Meghnagar, including DAP, NPK, and sulfuric acid capacities; expected commissioning by March 2026. Machinery orders placed, civil work nearly complete, trial production starting by March, commercial production from April 2026. The new plant has a revenue potential of around Rs. 1,000 crore at full capacity; first-year utilization expected at ~60%. No definite plans for capex beyond March 2026; future expansion contingent on successful completion of current projects and subsequent assessment of market conditions and cash accruals. Comp

Future growth expectations in sales/revenue/volumes?

The new plant commissioning in April FY27 has capacity to add ~₹1,000 crores in revenue with an expected 60% utilization in the first year. For FY26, Q4 revenue is expected to exceed the nine-month average of ~₹570 crores. Manufacturing operations aim to maintain EBITDA margins of 14-15%, sometimes reaching 16%. Trading (imports) revenue and volume will vary based on market demand and orders; currently, manufacturing is at full capacity. Post current expansions, further growth plans will be evaluated based on market conditions and cash accruals, with no immediate CAPEX plans beyond March 2026.

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects continued robust growth driven by strong fertilizer demand, higher sales volumes, and improved plant utilization. EBITDA margins for manufacturing are targeted to be maintained around 14-15%, sometimes reaching 16%. The new plant commencing in April is expected to add nearly Rs. 1,000 crores in revenue at full capacity; first-year utilization target is ~60%. Revenue for FY26 is expected to exceed the Rs. 570 crores average for the first nine months, indicating strong Q4 growth. PAT and EPS have already shown significant YoY increases (PAT doubled to Rs. 97 crore; EP

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders in specific numbers. It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. Future expansion projects, including the 50% expansion of NPK/DAP capacity at Meghnagar, are on track for commissioning by March 2026, indicating preparation for increased future orders. Management will assess demand inflows and order variants after the new plant is commissioned to decide on adding new variants or geographical areas. Trading/import volumes fluc

IN US

Sale is live|00:00:00left today

Krishana Phoschem LtdQ4 FY27Fertilizers & Agrochemicals

Krishana Phoschem Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹727P/E: 22.5Market Cap: ₹4.1K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 1

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 1

→The new plant commissioning in April FY27 has capacity to add ~₹1,000 crores in revenue with an expected 60% utilization in the first year.
→For FY26, Q4 revenue is expected to exceed the nine-month average of ~₹570 crores.
→Manufacturing operations aim to maintain EBITDA margins of 14-15%, sometimes reaching 16%.
→Trading (imports) revenue and volume will vary based on market demand and orders; currently, manufacturing is at full capacity.
→Post current expansions, further growth plans will be evaluated based on market conditions and cash accruals, with no immediate CAPEX plans beyond March 2026.
→The company targets sustainable volume growth supported by enhanced plant utilization beyond 100% and demand for varied fertilizer variants.
→Management is focused on balancing capacity expansion with profitability and farmer affordability.

Margin guidance

Category 3

→The company expects continued robust growth driven by strong fertilizer demand, higher sales volumes, and improved plant utilization.
→EBITDA margins for manufacturing are targeted to be maintained around 14-15%, sometimes reaching 16%.
→The new plant commencing in April is expected to add nearly Rs. 1,000 crores in revenue at full capacity; first-year utilization target is ~60%.
→Revenue for FY26 is expected to exceed the Rs. 570 crores average for the first nine months, indicating strong Q4 growth.
→PAT and EPS have already shown significant YoY increases (PAT doubled to Rs. 97 crore; EPS to Rs. 15.7 for nine months) with further growth expected.
→The Company aims to sustain profitability without aggressively raising prices despite cost pressures, leveraging operational efficiencies and government subsidies.
→Expansion projects are on track for strengthening operating performance and long-term growth visibility.

3 more insights locked — sign up free to unlock

Fundraise plans

→No immediate plans for new fundraising through debt or equity as the company's cash accruals and expansion plans are well synchronized.
→Shareholder approval for issuance of share debentures exists as an enabling provision to avoid last-minute rush if capital is needed, but currently, there is no requirement for additional capital.
→Future expansions beyond March 2026 will be funded primarily through internal cash profits, following past practices.
→The company will evaluate further plans after successful implementation of the current plant and year-end financial results.
→Listing on BSE is not currently under discussion, but the company may explore this possibility upon shareholder suggestion.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders in specific numbers.
→It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand.
→Future expansion projects, including the 50% expansion of NPK/DAP capacity at Meghnagar, are on track for commissioning by March 2026, indicating preparation for increased future orders.
→Management will assess demand inflows and order variants after the new plant is commissioned to decide on adding new variants or geographical areas.
→Trading/import volumes fluctuate based on market demand and orders from wholesalers and cooperative federations, making exact order book predictions difficult.
→No concrete figures on outstanding orders were provided during the Q&A.

Capex plans

Yes

→Current capex: Ongoing 50% expansion of NPK/DAP capacity at Meghnagar, including DAP, NPK, and sulfuric acid capacities; expected commissioning by March 2026.
→Machinery orders placed, civil work nearly complete, trial production starting by March, commercial production from April 2026.
→The new plant has a revenue potential of around Rs. 1,000 crore at full capacity; first-year utilization expected at ~60%.
→No definite plans for capex beyond March 2026; future expansion contingent on successful completion of current projects and subsequent assessment of market conditions and cash accruals.
→Company intends to fund expansions primarily through internal cash accruals.
→Management is actively evaluating new strategic opportunities to diversify and scale integrated growth operations.
→Shareholder approval for issuance of shared debentures is an enabling provision, but no immediate plans to raise capital this way.

How does Krishana Phoschem Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Krishana Phoschem Ltd

Rev 1Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Krishana Phoschem Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio